Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:05 June,2020
‘Telemedicine is new normal in healthcare, let’s accept it’
As Covid-19 outbreak began in India, Indian Council of Medical Research (ICMR) allowed telemedicine practice for doctors in the country. As we are moving towards a new normal, telemedicine is going to be a part of the new healthcare system, said Dr Amar Amale, interventional cardiologist at Arneja Heart Institute, while talking to TOI. According to him, people and doctors should accept it just the way we have accepted WhatsApp, video calls, Zoom and online payment options. Excerpts:....read more
CMAAO Coronavirus Facts and Myth Buster 117: Thrombo-Inflammation
(With inputs from Dr Monica Vasudev)
World Covid Meter 4th June 213 Countries: Wear mask at home
Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8; 5M May 20, 6M May 30
Fasting and starvation are two different terms commonly confused with each other.
Video of The dayCOVID and Cycling
Healthcare News Monitor
The Indian Express
The coronavirus count may be going up, but beyond the numbers, the pandemic is responsible for much stress as well. We worry about the future, how the situation will revert to normalcy and when we can see a glimmer of hope. On the occasion of World Environment Day, here is a list of some lifestyle changes that will help us maintain a healthy balance.
Sun Pharma gets approval to test plant-based dengue drug for Covid treatment
The printHIMANI CHANDNA
New Delhi: Sun Pharmaceutical, the country’s largest drugmaker, has received permission from the country’s apex drug regulatory body to start clinical trials of a plant-based drug, AQCH, to see if it can treat Covid-19 patients. It is the first phytopharmaceutical drug that the Drug Controller General of India (DCGI) has approved for clinical trial for Covid-19. Meant for the treatment of dengue, AQCH is still in the trial stage.